The reimbursement channel for digital health apps in Europe has traditionally been long and complex.
But new analysis from Research2Guidance (R2G) predicts reimbursement opportunities will improve significantly over the next few years.
An R2G report has categorised European countries into groups of leaders, fast followers, certifiers and laggards, based on their public health insurance system’s...
The German Federal Institute für Drugs and Medical Devices (BfArM) has added a new digital therapeutic to its digital health applications (DiGA) directory for public reimbursement.
Cara Care is the first DiGA that addresses gastroenterological issues and widespread digestive health problems such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), food and reflux intolerances.
The...
About the Author: Dr. Jossy Onwude is the cofounder and chief medical and product officer at Bold Health. He is a medical doctor, Health informatics fellow and a serial entrepreneur. To date, he has cofounded four digital health startups, with three still active and one successful exit. Currently, he leads the research and product development efforts at Bold Health – a digital therapeutics...
Funding news. Berlin-based digital health company Cara Care has secured $7m (€6.2m) in Series A funding in a round led by Johnson & Johnson Innovation and Asabys Partners. Existing investors Atlantic Labs also participated, bringing the total amount raised to over $9m (€8m).
Cara Care was founded by André Sommer and Jesaja Brinkmann in 2016, and it has developed a mobile app aiming to help...
